- New
-
Topics
- All Categories
- Metaphysics and Epistemology
- Value Theory
- Science, Logic, and Mathematics
- Science, Logic, and Mathematics
- Logic and Philosophy of Logic
- Philosophy of Biology
- Philosophy of Cognitive Science
- Philosophy of Computing and Information
- Philosophy of Mathematics
- Philosophy of Physical Science
- Philosophy of Social Science
- Philosophy of Probability
- General Philosophy of Science
- Philosophy of Science, Misc
- History of Western Philosophy
- Philosophical Traditions
- Philosophy, Misc
- Other Academic Areas
- Journals
- Submit material
- More
Ethical Guidance for Selecting Clinical Trials to Receive Limited Space in an Immunotherapy Production Facility
American Journal of Bioethics 18 (4):58-67 (2018)
Abstract
Our aims are to set forth a multiprinciple system for selecting among clinical trials competing for limited space in an immunotherapy production facility that supplies products under investigation by scientific investigators; defend this system by appealing to justice principles; and illustrate our proposal by showing how it might be implemented. Our overarching aim is to assist manufacturers of immunotherapeutic products and other potentially breakthrough experimental therapies with the ethical task of prioritizing requests from scientific investigators when production capacity is limited.Author's Profile
My notes
Similar books and articles
From protection to entitlement: selecting research subjects for early phase clinical trials involving breakthrough therapies.Nancy S. Jecker, Aaron G. Wightman, Abby R. Rosenberg & Douglas S. Diekema - 2017 - Journal of Medical Ethics 43 (6):391-400.
Stakeholder views of ethical guidance regarding prevention and care in HIV vaccine trials.Rika Moorhouse, Catherine Slack, Michael Quayle, Zaynab Essack & Graham Lindegger - 2014 - BMC Medical Ethics 15 (1):51.
Are explanatory trials ethical? Shifting the burden of justification in clinical trial design.Kirstin Borgerson - 2013 - Theoretical Medicine and Bioethics 34 (4):293-308.
What makes placebo-controlled trials unethical?Franklin G. Miller & Howard Brody - 2002 - American Journal of Bioethics 2 (2):3 – 9.
The Ethics of Placebo-controlled Trials: Methodological Justifications.Joseph Millum & Christine Grady - 2013 - Contemporary Clinical Trials 36 (2):510-14.
Conflicts among Multinational Ethical and Scientific Standards for Clinical Trials of Therapeutic Interventions.Jacob M. Kolman, Nelda P. Wray, Carol M. Ashton, Danielle M. Wenner, Anna F. Jarman & Baruch A. Brody - 2012 - Journal of Law, Medicine and Ethics 40 (1):99-121.
Is There a ‘Right to Try’ Experimental Therapies? Ethical Criteria for Selecting Patients With Spinal Muscular Atrophy to Receive Nusinersen in an Expanded Access Program.Nancy S. Jecker - 2017 - American Journal of Bioethics 17 (10):70-71.
Uncertainty and the ethics of clinical trials.Sven Ove Hansson - 2006 - Theoretical Medicine and Bioethics 27 (2):149-167.
Limited English Proficiency and Disparities in Clinical Research.Dan Bustillos - 2009 - Journal of Law, Medicine and Ethics 37 (1):28-37.
Are Phase 1 Trials Therapeutic? Risk, Ethics, and Division of Labor.James A. Anderson & Jonathan Kimmelman - 2012 - Bioethics 28 (3):138-146.
Trials are already being prioritised, just not at the institutional level.Simon Kolstoe - 2017 - Journal of Medical Ethics 43 (12):814-815.
Controversies: A case of insufficient evidence equipoise: the NICE guidance on antibiotic prophylaxis for the prevention of infective endocarditis.R. K. Mohindra - 2010 - Journal of Medical Ethics 36 (9):567-570.
Allowing Innovative Stem Cell-Based Therapies Outside of Clinical Trials: Ethical and Policy Challenges.Insoo Hyun - 2010 - Journal of Law, Medicine and Ethics 38 (2):277-285.
Using empirical data to inform the ethical evaluation of placebo controlled trials.Jeremy Sugarman - 2004 - Science and Engineering Ethics 10 (1):29-35.
Analytics
Added to PP
2018-04-06
Downloads
29 (#550,902)
6 months
15 (#167,130)
2018-04-06
Downloads
29 (#550,902)
6 months
15 (#167,130)
Historical graph of downloads
Author's Profile
Citations of this work
Prioritizing Facts and Values in Immunotherapy Trial Selection: Some Further Guidance.Valerye Milleson - 2018 - American Journal of Bioethics 18 (4):76-78.
Perverse Effects: How Insufficient Guidance to IPFs Can Undermine Both Research and Health Outcomes of Clinical Trials.John W. Frye - 2018 - American Journal of Bioethics 18 (4):78-80.
Resource Allocation in COVID-19 Research: Which Trials? Which Patients?Sarah Wieten, Alyssa Burgart & Mildred Cho - 2020 - American Journal of Bioethics 20 (7):86-88.
Disease Prevalence and the Magnitude of Research Benefits.Leah Pierson & Joseph Millum - 2018 - American Journal of Bioethics 18 (4):73-74.
Ethical Ruminations of a Rheumatologist: Autoimmunity Is an Important Consideration for Immunotherapy Trials.Jane S. Kang - 2018 - American Journal of Bioethics 18 (4):75-76.
References found in this work
Equality and equal opportunity for welfare.Richard J. Arneson - 1989 - Philosophical Studies 56 (1):77 - 93.
Sovereign Virtue: The Theory and Practice of Equality.R. M. Dworkin - 2002 - Philosophical Quarterly 52 (208):377-389.
Equality and Equal Opportunity for Welfare.Richard Arneson - 1997 - In Louis P. Pojman & Robert Westmoreland (eds.), Equality: Selected Readings. Oup Usa.
PhilPapers logo by Andrea Andrews and Meghan Driscoll.
This site uses cookies and Google Analytics (see our terms & conditions for details regarding the privacy implications). Use of this site is subject to terms & conditions.
All rights reserved by The PhilPapers Foundation
Server: philpapers-web-64dd777598-cl5t5 uwo